Century Therapeutics, Inc.

US$1.68As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IPSCHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (41.36%)
Div yield —
ROE (49.65%)
Biotechnology
Beta (5Y) 1.77
PE TTM —
TSR TTM 188.12%
Mkt cap US$304.2M
ROIC (25.24%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.93
14.75%
(46.39%)
Hold 4|8|1|0|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.04
22.01%
14.30%
4.53%
8.40%
Revenue$M
16.49
17.46
17.85
18.90
13.20%
13.76%
13.81%
19.74%
Peers (US$304.2M)
Cap (US$)
PE
304.7M
28.60x
Capital
TTM
5Y
10Y
Leveragex
0.877
(1.109)
(1.105)
EBIT/Intx
0.527
0.284
0.285
Own earn%
221.30
27.68
30.54
Sh yield%
34.91
54.08
56.16
Owners
Insiders/Inst%
6.13
34.33
Short interest%
0.62
SBC / revenue%
4.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
29–35
$1 testx
—
Incr. ROIC%
3